Evidence map›Paper›PMID 28823165›Full record

ArticleJournal of the American Chemical Society2017

Evaluation of

Nilantha Bandara, Anuj K Sharma, Stephanie Krieger, Jason W Schultz, Byung Hee Han, Buck E Rogers, Liviu M Mirica

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ACS omega · 2022
    Article
  13. 2-(4-Hydroxyphenyl)benzothiazole dicarboxylate ester TACN chelators forDalton transactions (Cambridge, England : 2003) · 2022
    Article
  14. Article
  15. Article
  16. Design of a multivalent bifunctional chelator for diagnosticProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Metals in Imaging of Alzheimer's Disease.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nilantha BandaraMallinckrodt Institute of Radiology, Washington University School of Medicine , St. Louis, Missouri 63110, United States.
Anuj K SharmaDepartment of Chemistry, Washington University , One Brookings Drive, St. Louis, Missouri 63130, United States.
Stephanie KriegerDepartment of Radiation Oncology, Washington University School of Medicine , St. Louis, Missouri 63108, United States.
Jason W SchultzDepartment of Chemistry, Washington University , One Brookings Drive, St. Louis, Missouri 63130, United States.
Byung Hee HanDepartment of Pharmacology, A.T. Still University of Health Sciences, Kirksville College of Osteopathic Medicine , Kirksville, Missouri 63501, United States.
Buck E RogersMallinckrodt Institute of Radiology, Washington University School of Medicine , St. Louis, Missouri 63110, United States.
Liviu M MiricaDepartment of Chemistry, Washington University , One Brookings Drive, St. Louis, Missouri 63130, United States.ORCID 0000-0003-0584-9508

Funding

WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
NOVEL BIFUNCTIONAL CHEMICAL AGENTS AS THERANOSTIC TOOLS FOR AMYLOID DISEASESR01GM114588 · NIGMS · WASHINGTON UNIVERSITY · PI MIRICA, LIVIU M. · 2015 to 2019
$1.4M
NIA NIH HHS P50 AG005681NIGMS NIH HHS R01 GM114588
6 · The paper itself

Abstract

Positron emission tomography (PET) imaging agents that detect amyloid plaques containing amyloid beta (Aβ) peptide aggregates in the brain of Alzheimer's disease (AD) patients have been successfully developed and recently approved by the FDA for clinical use. However, the short half-lives of the currently used radionuclides

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsAutoradiographyCopper RadioisotopesHalf-LifeHumansMiceMice, TransgenicMultimodal ImagingRadiopharmaceuticalsSpectrometry, FluorescenceTissue DistributionAmyloid beta-PeptidesCopper-64Copper RadioisotopesRadiopharmaceuticals

Identifiers

PMID28823165
PMCPMC5677763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.